PERRIGO PLC (Israel) Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for PERRIGO PLC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 22, 2019 and ending today November 20, 2019. Click here to learn more.
PERRIGO PLC cannot be verified against its exchange. Apparently, PERRIGO PLC is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

PERRIGO PLC Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. PERRIGO PLC operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 10600 people.. The public information regarding PERRIGO PLC's current market price is not available at this time.
NamePERRIGO PLC
President CEO, DirectorUwe RohrhoffView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressThe Sharp Building
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.perrigo.com
Phone353 1 709 4000
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 30, 2019
Last Fiscal Year EndDecember 31, 2018
PERRIGO PLC (PRGO) is traded on Tel Aviv Stock Exchange in Israel and employs 10,600 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 2590 B. PERRIGO PLC operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 135.99 M outstanding shares. PERRIGO has accumulated about 841.6 M in cash with 515.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check PERRIGO PLC Probability Of Bankruptcy

PERRIGO PLC Key Fundamentals

PERRIGO PLC Against Markets

PERRIGO PLC cannot be verified against its exchange. Apparently, PERRIGO PLC is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. PERRIGO PLC operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 10600 people.. The public information regarding PERRIGO PLC's current market price is not available at this time.
NamePERRIGO PLC
President CEO, DirectorUwe RohrhoffView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressThe Sharp Building
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.perrigo.com
Phone353 1 709 4000
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 30, 2019
Last Fiscal Year EndDecember 31, 2018

PERRIGO PLC Corporate Directors

Gary Cohen Independent Director
Laurie Brlas Independent Director
Donal OConnor Independent Director
See also Your Equity Center. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com